Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 19, 2023
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Decreased Target to $110 on, Oct 19th, 2023
Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $123 to $110 on, Oct 19th, 2023.
Jayson has made no other calls on ABT in the last 4 months.
There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 2 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mike Polark of "Wolfe Research" Upgraded from Sell to Hold on, Friday, July 21st, 2023
- Anthony Petrone of "Mizuho" Initiated at Hold with Increased Target to $115 on, Friday, July 21st, 2023
This is the rating of the analyst that currently disagrees with Jayson
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $122 on, Monday, October 2nd, 2023
